Your browser doesn't support javascript.
loading
Audits of collection and apheresis centers: guidelines by the World Marrow Donor Association Working Group Quality and Regulation.
Lara-Weisshaupt, Elena; Tistl, Ingrid; Hale, Kuchen; Torosian, Tigran; Schlaphoff, Terry; Manor, Sigal; Jindra, Pavel; Schöffel-Weiß, Sabine; Audat, Françoise; Abress, Linda; Pingel, Julia.
Afiliación
  • Lara-Weisshaupt E; DKMS, Tübingen, Germany.
  • Tistl I; Zentrales Knochenmarkspender-Register Deutschland (ZKRD), Ulm, Germany.
  • Hale K; National Marrow Donor Program, Minneapolis, USA.
  • Torosian T; Fundacja DKMS, Warsaw, Poland.
  • Schlaphoff T; South African Bone Marrow Registry, Cape Town, South Africa.
  • Manor S; Ezer Mizion Bone Marrow Donor Registry, Petah-Tikva, Israel.
  • Jindra P; Czech National Marrow Donors Registry, Pilsen, Czech Republic.
  • Schöffel-Weiß S; Cellex Medical Services GmbH, Köln, Germany.
  • Audat F; Agence de la Biomedecine, RFGM, Saint-Denis, France.
  • Abress L; National Marrow Donor Program, Minneapolis, USA.
  • Pingel J; DKMS, Tübingen, Germany. pingel@dkms.de.
Bone Marrow Transplant ; 54(2): 244-257, 2019 02.
Article en En | MEDLINE | ID: mdl-30108327
According to the Standards of the World Marrow Donor Association (WMDA), unrelated stem cell donor registries and donor centers are responsible for compliance of their collection and apheresis centers with these Standards. To ensure high stem cell product quality and high standards for safety and satisfaction of voluntary unrelated stem cell donors, we here present guidelines for audits of collection and apheresis centers that can be used by new and established donor registries, as well as by collection centers in preparation of audits. We define the general requirements and recommendations for collaboration with the collection and apheresis centers and define critical procedures for the collection of the stem cell product, such as information session, medical assessment, product collection, quality controls, product handover for transportation, and donor follow-up. The specific guidelines are accompanied by detailed checklists and forms that can be found in Supplementary Information and may be used during an initial or follow-up on-site or paper-based audit.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Control de Calidad / Bancos de Sangre / Eliminación de Componentes Sanguíneos Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Control de Calidad / Bancos de Sangre / Eliminación de Componentes Sanguíneos Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido